Document Detail


Neutrophil predominance in induced sputum from asthmatic patients. Therapeutic implications and role of clara cell 16-KD protein.
MedLine Citation:
PMID:  21893447     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
IN CONCLUSION: a NP subset of asthmatic patients was identified. These patients show a lower bronchial lability; the leukotriene pathway is involved which responds to anti-leukotriene treatment. This phenotype shows a poor recovery of CC16 level after treatment.
Authors:
Elisa M Uribe Echevarría; Cristina A Maldonado; Agustín M Uribe Echevarría; Agustín Aoki
Related Documents :
20515677 - Polyamine patterns in the cerebrospinal fluid of patients with parkinson's disease and ...
22736247 - Negative effect of immunosuppressive therapy in the performance of the quantiferon gold...
22700707 - Virological analysis in patients with human herpes virus 6-associated ocular inflammato...
7936287 - Nigral degeneration in neuroacanthocytosis.
9578027 - Clinical usefulness of the dipole tracing method for localizing interictal spikes in pa...
19664627 - Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab ...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Medicina     Volume:  71     ISSN:  0025-7680     ISO Abbreviation:  Medicina (B Aires)     Publication Date:  2011  
Date Detail:
Created Date:  2011-09-06     Completed Date:  2012-06-06     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  0204271     Medline TA:  Medicina (B Aires)     Country:  Argentina    
Other Details:
Languages:  eng     Pagination:  343-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetates / therapeutic use
Adult
Anti-Asthmatic Agents / therapeutic use*
Anti-Inflammatory Agents / therapeutic use*
Asthma / drug therapy*,  pathology,  physiopathology
Budesonide / therapeutic use
Cell Count
Drug Therapy, Combination
Eosinophils / cytology*,  drug effects
Female
Humans
Male
Neutrophils / cytology*,  drug effects
Quinolines / therapeutic use
Severity of Illness Index
Single-Blind Method
Sputum / cytology*
Uteroglobin / physiology
Young Adult
Chemical
Reg. No./Substance:
0/Acetates; 0/Anti-Asthmatic Agents; 0/Anti-Inflammatory Agents; 0/Quinolines; 0/SCGB1A1 protein, human; 51333-22-3/Budesonide; 9060-09-7/Uteroglobin; MHM278SD3E/montelukast

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  [Ultraviolet radiation impact on seasonal variations of serum 25-hydroxy-vitamin D in healthy young ...
Next Document:  [Antibody deficiencies. A survey from three Clinical Immunology Centers for adults in Buenos Aires C...